한글목차

세계의 세포주 및 세포막 시장 규모는 2024년 57억 달러, 2025년 63억 달러에서 2030년에는 114억 달러에 달할 것으로 예측되며, 2025년부터 2030년까지의 예측 기간 동안 CAGR 12.5%로 성장할 전망입니다.

북미 시장은 2024년 30억 달러, 2025년 33억 달러에서 2030년에는 59억 달러에 이를 것으로 예측되며, 2025년부터 2030년까지 예측 기간 동안 CAGR 12.4%로 성장할 전망입니다.

본 보고서에서는 세계의 세포주 및 세포막 시장을 조사했으며, 시장 개요, 시장영향인자 및 시장 기회 분석, 법규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이와 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요기업의 프로파일 등을 정리했습니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약
• 시장 성장 요인
• 신기술
• 세분화 분석
• 지역 분석
• 총론

제2장 시장 개요

• 개요 및 시장의 정의
• 기술적 배경
• 세포주 개발 및 세포 배양
• 공급망 분석
• 원재료 조달
• 제조 및 개발 프로세스
• 최종 사용자
• Porter's Five Forces 분석
• PESTEL 분석
• 전략적 제안

제3장 시장 역학

• 개요
• 시장 성장 촉진요인
• 기술의 발전 세포주 규모 확대 가속화
• 제약기업과 생명공학기업의 의약품 개발 투자 증가
• 세포 기반 분석에서 세포주 기술 채택 증가
• 세포 배양 백신 수요 증가
• 시장 성장 억제요인
• 세포 생물학 연구의 높은 비용
• 숙련된 전문 인력 부족
• 시장 기회
• 단일 클론 항체의 승인 건수 증가
• 세포치료 및 재생의료의 확대

제4장 규제 상황

• 세포주 및 세포막 시장에서의 규제와 기준
• 미국
• EU
• 중국
• 인도
• 일본
• 브라질

제5장 신기술과 새로운 개발

• 신기술
• 유전자 편집
• 자동화
• 고효율 스크리닝

제6장 시장 세분화 분석

• 세분화 분석
• 시장 분석 : 제품별
• 핵심 요약
• 세포주
• 세포막
• 시장 분석 : 출처별
• 핵심 요약
• 포유류 세포주
• 비포유류 세포주
• 시장 분석 : 용도별
• 핵심 요약
• 기초 연구
• 바이오 의약품 제조
• 신약 개발
• 독성 시험
• 조직 공학
• 기타
• 시장 분석 : 최종 사용자별
• 핵심 요약
• 생명공학 및 제약회사
• 학술연구기관
• 기타
• 지리적 세분화
• 시장 분석 : 지역별
• 핵심 요약
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제7장 경쟁 정보

• 핵심 요약
• 주요 기업 순위
• 전략 분석
• 협정, 협력, 파트너십
• 신제품 발매
• M&A
• 확장
• 기타

제8장 세포주 및 세포막 시장에서의 지속 가능성 : ESG의 관점

• 세포주 및 세포막 시장에서의 지속가능성
• ESG 위험 평가 : 데이터 이해
• ESG 성능 분석
• 환경 성과
• 사회적 성과
• 거버넌스 성과
• 결론

제9장 부록

• 조사 방법
• 약어
• 참고문헌
• 기업 프로파일
• AGC BIOLOGICS
• ATCC
• CATALENT INC.
• CELL BIOLABS INC.
• CREATIVE BIOLABS
• CROWN BIOSCIENCE
• FUJIFILM CELLULAR DYNAMICS INC.
• IXCELLS BIOTECHNOLOGIES
• KBI BIOPHARMA
• LONZA
• MILTENYI BIOTEC
• PROMEGA CORP.
• PROMOCELL GMBH
• PROBIOGEN AG
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

The North American market for cell lines and membranes was valued at $3.0 billion in 2024 and is estimated to increase from $3.3 billion in 2025 to reach $5.9 billion by 2030, at a CAGR of 12.4% from 2025 through 2030.

The Asia-Pacific market for cell lines and membranes was valued at $988.8 million in 2024 and is estimated to increase from $1.1 billion in 2025 to reach $2.2 billion by 2030, at a CAGR of 14.3% from 2025 through 2030.

Report Scope

This report provides an overview of the global cell line and membrane market and analyzes market trends. It includes global revenue ($ millions) for base year data 2024, estimated data for 2025 and forecast data from 2026 to 2030. The market is segmented based on product types, subtypes, applications, end users and regions. The regions covered in this study are North America, Europe, Asia-Pacific and the Rest of the World (RoW), focusing on major countries within these regions.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key players in the global cell line and membrane market. It also has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.

Report Includes

• 54 data tables and 67 additional tables
• An overview of the global market for cell lines and membranes
• An analysis of the global market trends, with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
• Discussion of the current and future market potential, and quantification of the market by product type, source, end use industry, application, and geographic region
• Identification of applications of cell lines in drug development, diagnostics, and molecular biology
• Description of advances in cell lines for cancer-based therapies
• Details about CAR-T cell and immune check point inhibitor therapy
• Comparison of the manufacturing processes for autologous and allogenic cells
• Explanation of the increasing adoption of cell line technologies in cell-based assay and the surging demand of antibody production
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, and ESG trends of the market
• Analysis of the key companies' market shares and proprietary technologies, strategic alliances, and patent portfolios
• Company profiles of major players within the industry, including ATCC, Catalent Inc., Lonza, and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview and Market Definition
• Technology Background
• Development of Cell Lines and Cell Culture
• Supply Chain Analysis
• Procurement of Raw Materials
• Manufacturing and Development Process
• End Users
• Porter's Five Forces Analysis
• Threat of New Entrants: Medium
• Bargaining Power of Suppliers: Medium
• Bargaining Power of Buyers: Medium
• Threat of Substitute: Medium
• Industry Rivalry: High
• PESTEL Analysis
• Political
• Economical
• Social
• Technological
• Environmental
• Legal
• Strategic Recommendations

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Advances in Technologies Accelerating the Scale-Up of Cell Lines
• Rising Investments by Pharmaceutical and Biotechnology Companies in Drug Development
• Increasing Adoption of Cell Line Technologies in Cell-Based Assays
• Growing Demand for Cell Culture-Based Vaccines
• Market Restraints
• High Cost of Cell Biology Research
• Shortage of Skilled Professionals
• Market Opportunities
• Increasing Number of Approvals for Monoclonal Antibody Types
• Expansion of Cell Therapy and Regenerative Medicine

Chapter 4 Regulatory Landscape

• Regulations and Standards in Cell Line and Membrane Market
• U.S.
• European Union
• China
• India
• Japan
• Brazil

Chapter 5 Emerging Technologies and New Developments

• Emerging Technologies
• Gene Editing
• Automation
• High-Throughput Screening

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Product
• Key Takeaways
• Cell Lines
• Cell Membrane
• Market Breakdown by Source
• Key Takeaways
• Mammalian Cell Lines
• Non-Mammalian Cell Lines
• Market Breakdown by Application
• Key Takeaways
• Basic Research
• Biopharmaceutical Production
• Drug Discovery
• Toxicity Testing
• Tissue Engineering
• Others
• Market Breakdown by End User
• Key Takeaways
• Biotechnology and Pharmaceutical Companies
• Academic and Research Institutes
• Other End Users
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Top Players Ranking, 2024
• Strategic Analysis
• Agreements, Collaborations and Partnerships
• New Product Launches
• Mergers and Acquisitions
• Expansions
• Other Strategic Alliances

Chapter 8 Sustainability in the Cell Line and Membrane Market: ESG Perspective

• Sustainability in the Cell Line and Membrane Market
• ESG Risk Ratings: Understanding the Data
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks

Chapter 9 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• AGC BIOLOGICS
• ATCC
• CATALENT INC.
• CELL BIOLABS INC.
• CREATIVE BIOLABS
• CROWN BIOSCIENCE
• FUJIFILM CELLULAR DYNAMICS INC.
• IXCELLS BIOTECHNOLOGIES
• KBI BIOPHARMA
• LONZA
• MILTENYI BIOTEC
• PROMEGA CORP.
• PROMOCELL GMBH
• PROBIOGEN AG
• THERMO FISHER SCIENTIFIC INC.